[ET Net News Agency, 23 March 2021] Sino Biopharmaceutical Limited (01177) said for the
year ended 31 December 2020, profit attributable to the owners of the parent was
RMB2,771.09 million, a slight increase of 0.3% over the last year. Basic earnings per
share were RMB14.74 cents. The board has recommended a final dividend of HK2 cents.
Revenue was RMB23,647.22 million, dropped marginally by 2.4% over the last year. (RC)